Vyvanse is a central nervous system (CNS) stimulant indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe binge eating disorder. The new 10mg strength is intended as a titration dose for patients with ADHD.
Vyvanse is a prodrug of dextroamphetamine. Amphetamines block the reuptake of norepinephrine and dopamine in the presynaptic neuron and increase the release of these monoamines in the extraneuronal space.
Vyvanse, a CII controlled substance, is already available in 20mg, 30mg, 40mg, 50mg, 60mg, and 70mg strength capsules in 100-count bottles.
For more information call (800) 828-2088 or visit Vyvanse.com.